Instructions For Authors
These instructions help authors prepare clear, ethical, and reproducible manuscripts for Journal of New Developments in Molecular Biology (JNMB). Submissions should emphasize mechanistic insight, methodological transparency, and strong evidence supporting molecular conclusions.
Accepted Article Categories
Original research with mechanistic validation
Systematic and narrative reviews
Methods and protocol papers
Short communications and rapid notes
Data resources and genome reports
Perspectives and technology outlooks
Manuscript Structure
Most research papers should include Title, Abstract, Keywords, Introduction, Methods, Results, and Discussion. Provide detailed experimental designs, replicate counts, and analytic steps that allow replication across laboratories.
Abstracts should summarize objectives, methods, results, and conclusions. Use clear gene symbols, pathway names, and cell type descriptors to aid discovery.
Discussion sections should interpret results in context of existing literature and explain the biological significance of findings.
Formatting And Style
Use clear headings, consistent terminology, and standard units. Figures should be high resolution and include scale bars, annotations, and legend clarity. Provide raw or processed data where appropriate.
Tables should be editable and include units. Avoid excessive abbreviations and define all acronyms at first use.
Follow standard nomenclature for genes, proteins, and species to maintain consistency across the field.
Methods Transparency
Describe reagents, cell lines, model systems, and software versions with sufficient detail for replication. Include catalog numbers, suppliers, and reference sequences where applicable.
Specify statistical methods, error bars, and thresholds. Report replicates and clarify whether data are biological or technical.
For imaging or sequencing assays, include instrument settings, platform versions, and quality control parameters.
Reporting Standards
Adhere to relevant reporting guidelines such as ARRIVE, MIQE, PRISMA, or domain specific checklists. Thorough reporting improves reproducibility and strengthens peer review outcomes.
For omics studies, include data processing pipelines, normalization strategies, and quality control metrics.
Provide supplemental methods when workflows are extensive, including code or workflow diagrams if helpful.
Ethics And Compliance
For studies involving human samples, animal models, or sensitive datasets, include approval identifiers and consent statements. Ensure biosafety compliance for gene editing or pathogen related work.
Provide statements on informed consent, deidentification methods, and ethical review boards when applicable.
For CRISPR or gain of function studies, describe containment and risk mitigation procedures.
Data Availability
Include a data availability statement with accession numbers for sequence data, proteomics repositories, or structural databases. If restrictions apply, explain access limitations and provide controlled access options.
Share code and analysis scripts when possible to enable validation and reuse.
Ensure repository links are persistent and include version identifiers or DOIs.
Authorship And Contributions
List all contributors who meet authorship criteria and provide a contribution statement. Use CRediT roles when possible to clarify responsibilities for study design, analysis, and writing.
All authors must approve the final manuscript and accept responsibility for the integrity of the work.
Disputes about authorship must be resolved by the submitting institution prior to submission.
Conflicts And Funding
Disclose all financial or institutional relationships that could influence the work. Provide funding sources and grant numbers to support transparency and compliance with sponsor requirements.
Failure to disclose conflicts may result in rejection or post publication corrections.
Industry funded studies should clearly describe sponsor involvement in study design and data interpretation.
Plagiarism And Originality
All submissions undergo originality checks. Manuscripts with redundant publication or uncredited reuse will be returned. Clearly cite prior work and explain what is novel.
If a study extends a preprint or conference abstract, describe the new analyses and added value.
Reuse of methods text should be limited and fully cited.
Peer Review Model
JNMB uses single blind peer review. Reviewers remain anonymous to authors while editor decisions are based on methodological rigor, novelty, and biological relevance.
Editors may request additional data or validation experiments to support key claims.
Revisions should address reviewer comments directly and provide evidence for changes.
Revisions And Appeals
Provide a point by point response to reviewer comments and highlight changes in the manuscript. Clear revisions speed decision timelines.
Appeals should include scientific justification and will be reviewed by senior editors independent of the initial decision.
Rebuttals should be professional, evidence based, and focused on the science.
After Acceptance
Accepted manuscripts undergo copyediting and proof review. Authors must approve final proofs and confirm accuracy before publication.
APC billing is issued only after acceptance and is independent of editorial decision making.
Early online publication enables rapid citation and dissemination to the molecular community.
Submission Pathways
Authors may submit via ManuscriptZone for full tracking or use the simple submission form for a faster upload. Both routes receive the same editorial treatment.
Ensure all files are included, including figures, supplementary data, and a cover letter describing novelty and scope fit.
Incomplete submissions may be returned for completion before peer review.
Language Support
Authors seeking language editing support can contact the editorial office before submission. Editing does not influence editorial decisions or acceptance.
Well structured language improves reviewer comprehension and reduces revision cycles.
Provide a list of preferred technical terms to maintain consistent nomenclature.
Figure And Table Preparation
Figures should be provided at high resolution with clear labels and color schemes that remain legible when printed. Provide separate files for each figure and include captions in the manuscript.
For multi panel figures, label panels consistently and describe each in the caption.
Figure manipulation should be limited to brightness or contrast adjustments applied uniformly.
Supplementary Materials
Use supplementary files for extended datasets, additional figures, or detailed protocols. Clearly reference supplementary content within the main text.
Supplementary materials are hosted alongside the article and should meet the same formatting and ethics standards as the main manuscript.
Provide descriptive filenames and a table of contents for large supplemental packages.
Preprints And Prior Dissemination
JNMB welcomes submissions previously posted as preprints. Disclose preprint DOIs and update the preprint record with the published version once available.
Conference abstracts and theses are acceptable as prior dissemination when the submitted manuscript provides substantial new analysis.
Cover Letter Guidance
Use the cover letter to summarize novelty, mechanistic contribution, and alignment with JNMB scope. Suggest potential reviewers and declare any conflicts of interest.
A strong cover letter helps editors assign the best reviewers and accelerate screening.
Before submission: verify ethics approvals, include accession numbers, provide data availability statements, confirm figure citations, and ensure all abbreviations are defined.
Ready To Submit To JNMB?
Choose your preferred submission method. For questions, email [email protected].
Statistical Reporting
Report statistical tests, assumptions, effect sizes, confidence intervals, and exact p values where possible. Clearly differentiate exploratory analyses from confirmatory tests.
For multi group comparisons, describe correction methods and provide justification for selected thresholds.
Image Integrity
Image processing should be applied uniformly and described in the methods. Do not remove features or alter background in a way that changes interpretation.
Provide original or uncropped images when requested during review.
Omics Reporting
For transcriptomics, proteomics, or metabolomics studies, describe normalization, batch correction, and quality control procedures in detail.
Include accession numbers and provide links to processed matrices along with raw files when possible.
Replication And Validation
Clearly state biological versus technical replicates and justify sample sizes. Validation experiments or orthogonal assays strengthen mechanistic claims.
Include negative and positive controls where appropriate to support reproducibility.
Data And Code Citation
Cite datasets and software tools in the reference list using DOIs or accession numbers. Proper citation supports credit and improves reuse tracking.
If code is hosted on Git repositories, include version numbers and release tags to ensure reproducibility.
Reagent Transparency
Report cell line authentication status, contamination testing, and reagent validation when applicable. These details improve confidence in molecular findings.
Provide catalog numbers and RRIDs where possible to support replication.
Data Visualization
Ensure plots and figures are readable at journal layout size. Use legible fonts, consistent color schemes, and clear axis labels.
Avoid unnecessary embellishments that obscure quantitative interpretation.
Replication Notes
Explicitly state replication strategy and validation methods. Where applicable, include independent validation datasets or orthogonal assays.
Replication details improve reviewer confidence and strengthen conclusions.
Materials And Reagents
List sources of key reagents, antibodies, and constructs. Provide RRIDs when available to improve reproducibility.
If custom reagents are used, include details on validation and availability.
Clinical Translation
When discussing translational implications, be clear about limitations and required validation steps. Avoid overstatement of clinical readiness.
Balanced interpretation improves credibility and peer review outcomes.
Compliance Checklist
Confirm that all approvals, accession numbers, and funding disclosures are included before submission. A complete checklist reduces editorial queries.
Author Contact
Ensure the corresponding author email is current and monitored for review updates and proof checks.
